Cargando…
l‐Homoarginine supplementation prevents diabetic kidney damage
l‐homoarginine is an endogenous, non‐proteinogenic amino acid that has emerged as a new player in health and disease. Specifically, low l‐homoarginine levels are associated with cardiovascular diseases, stroke, and reduced kidney function. However, the role of l‐homoarginine in the pathogenesis of d...
Autores principales: | Wetzel, Michael D., Gao, Ting, Venkatachalam, Manjeri, Morris, Sidney M., Awad, Alaa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759505/ https://www.ncbi.nlm.nih.gov/pubmed/31552707 http://dx.doi.org/10.14814/phy2.14235 |
Ejemplares similares
-
Homoarginine ameliorates diabetic nephropathy independent of nitric oxide synthase‐3
por: Wetzel, Michael D., et al.
Publicado: (2021) -
Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction
por: Kleist, Christine J., et al.
Publicado: (2022) -
Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
por: Ravani, Pietro, et al.
Publicado: (2013) -
Homoarginine Supplementation Prevents Left Ventricular Dilatation and Preserves Systolic Function in a Model of Coronary Artery Disease
por: Rodionov, Roman N., et al.
Publicado: (2019) -
Evaluation of the predictive values of elevated serum l-homoarginine and dimethylarginines in preeclampsia
por: Yuan, Xiangmei, et al.
Publicado: (2022)